Maestas Nicholas 4
4 · Tempest Therapeutics, Inc. · Filed Jul 14, 2021
Insider Transaction Report
Form 4
Maestas Nicholas
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
[F1]2021-07-12+23,225→ 23,225 totalExercise: $24.19Exp: 2031-07-11→ Common Stock (23,225 underlying)
Footnotes (1)
- [F1]One-fourth of the shares underlying this option vest on July 12, 2022, and the remaining shares vest in a series of 36 equal monthly installments thereafter, subject to the reporting person's continued service.
Signature
/s/ Pierre Lorenzo, attorney-in-fact for Nicholas Maestas|2021-07-14